Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3283-3287

  Bogaerts, Pierre ^a   Bebrone, Carine ^b   Huang, Te Din ^a   Bouchahrouf, Warda ^a   DeGheldre, Yves ^c   Deplano, Ariane ^d   Hoffmann, Kurt ^b   Glupczynski, Youri ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Centre Hospitalier interregional Edith Cavell   (Belgium)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; DORIPENEM; ERTAPENEM; GENTAMICIN; HISTIDINE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PLASMID DNA; TEMOCILLIN; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN; TYROSINE; UNCLASSIFIED DRUG; VIM 2 PROTEIN; VIM 31 PROTEIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD SAMPLING; ENTEROBACTER CLOACAE; ENZYME ANALYSIS; EPSILOMETER TEST; ESCHERICHIA COLI; GENE SEQUENCE; INTEGRON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPORATION; ENTEROBACTER CLOACAE; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION;

EID: 84861140785     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06249-11     Document Type: Article

References (39)

1. Ausubel FM, et al. 2000. Current protocols in molecular biology. John Wiley & Sons, Inc, New York, NY.
2. Bebrone C, et al. 2008. Mutational analysis of the zinc- and substrate-binding sites in the CphA metallo-beta-lactamase from Aeromonas hydrophila. Biochem. J. 414:151-159.
3. Bogaerts P, Bauraing C, Deplano A, Glupczynski Y. 2007. Emergence and dissemination of BEL-1-producing Pseudomonas aeruginosa isolates in Belgium. Antimicrob. Agents Chemother. 51:1584-1585. (Pubitemid 46586861)
4. Bogaerts P, et al. 2011. Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece. Antimicrob. Agents Chemother. 55:4488-4489.
5. Bogaerts P, et al. 2007. Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J. Antimicrob. Chemother. 59:459-464. (Pubitemid 47073451)
6. Bogaerts P, et al. 2008. Nosocomial infections caused by multidrugresistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases. J. Antimicrob. Chemother. 61:749-751. (Pubitemid 351321158)
7. Borra PS, et al. 2011. Structural and computational investigations of VIM-7: insights into the substrate specificity of VIM metallo-beta-lactamases. J. Mol. Biol. 411:174-189.
8. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
9. Choi KH, Kumar A, Schweizer HP. 2006. A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J. Microbiol. Methods 64:391-397. (Pubitemid 43212814)
10. Chouchani C, Marrakchi R, Ferchichi L, El Salabi A, Walsh TR. 2011. VIM and IMP metallo-beta-lactamases and other extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from environmental samples in a Tunisian hospital. APMIS 119:725-732.
11. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Docquier JD, et al. 2003. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J. Antimicrob. Chemother. 51:257-266.
13. El Garch F, Bogaerts P, Bebrone C, Galleni M, Glupczynski Y. 2011. OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55:4828-4833.
14. Garau G, et al. 2004. Update of the standard numbering scheme for class B beta-lactamases. Antimicrob. Agents Chemother. 48:2347-2349. (Pubitemid 38823395)
15. Garcia-Saez I, Docquier JD, Rossolini GM, Dideberg O. 2008. The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. J. Mol. Biol. 375:604-611. (Pubitemid 350297297)
16. Gomez S, et al. 2011. Emergence of metallo-beta-lactamases in Enterobacteriaceae from Argentina. Diagn. Microbiol. Infect. Dis. 69:94-97.
17. Jeong SH, et al. 2003. Characterization of a new integron containing VIM-2, a metallo-beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J. Antimicrob. Chemother. 51:397-400. (Pubitemid 36231163)
18. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. (Pubitemid 14046088)
19. Kontou M, et al. 2007. Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-beta-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity. Biochemistry 46:13170-13178. (Pubitemid 350086235)
20. Lagatolla C, et al. 2006. Molecular evolution of metallo-beta-lactamase- producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J. Clin. Microbiol. 44:2348-2353. (Pubitemid 44092397)
21. Laraki N, et al. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother. 43:902-906. (Pubitemid 29165755)
22. Lassaux P, et al. 2011. Biochemical and structural characterization of the subclass B1 metallo-beta-lactamase VIM-4. Antimicrob. Agents Chemother. 55:1248-1255.
23. Lee EH, et al. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob. Agents Chemother. 35:1093-1098.
24. Lee HW, Kang HY, Shin KS, Kim J. 2007. Multidrug-resistant Providencia isolates carrying bla(PER-1), bla(VIM-2), and armA. J. Microbiol. 45:272-274. (Pubitemid 47037763)
25. Levesque C, Piche L, Larose C, Roy PH. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
26. Marchiaro P, et al. 2008. Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain. Antimicrob. Agents Chemother. 52:2250-2252. (Pubitemid 351758571)
27. Materon IC, Beharry Z, Huang WZ, Perez C, Palzkill T. 2004. Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1. J. Mol. Biol. 344:653-663. (Pubitemid 39469210)
28. Morfin-Otero R, Rodriguez-Noriega E, Deshpande LM, Sader HS, Castanheira M. 2009. Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program. Microb. Drug Resist. 15:33-35.
29. Moura A, et al. 2009. INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinformatics 25:1096-1098.
30. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. 2011. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J. Clin. Microbiol. 49:1608-1613.
31. Papagiannitsis CC, et al. 2011. Characterization of metallo-beta- lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147. Antimicrob. Agents Chemother. 55:3570-3572.
32. Patel G, Bonomo RA. 2011. Status report on carbapenemases: challenges and prospects. Expert Rev. Anti Infect. Ther. 9:555-570.
33. Prosperi-Meys C, et al. 1999. Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases. FEBS Lett. 443:109-111. (Pubitemid 29078612)
34. Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. 2010. VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
35. Rodriguez-Villalobos H, et al. 2011. Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J. Antimicrob. Chemother. 66:37-47.
36. Samuelsen O, Castanheira M, Walsh TR, Spencer J. 2008. Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family. Antimicrob. Agents Chemother. 52:2905-2908.
37. Scotta C, et al. 2011. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases. Antimicrob. Agents Chemother. 55:5376-5379.
38. Struelens MJ, et al. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498. (Pubitemid 23334688)
39. Yan JJ, Ko WC, Chuang CL, Wu JJ. 2002. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50:503-511.